Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Unraveling the Genetic Basis of Nicotine Addiction for Novel Therapeutic Strategies — Stella

Home/Smoking Cessation/Unraveling the Genetic Basis of Nicotine Addiction for Novel Therapeutic Strategies

View on ClinicalTrials.gov

Recruiting

Back to Smoking Cessation trials

Unraveling the Genetic Basis of Nicotine Addiction for Novel Therapeutic Strategies

Trial locations(1 site)

Cyprus

Center for Applied Neuroscience (CAN), Nicosia

Key details

Sponsor

University of Cyprus

Enrollment target

~200 participants

Started

November 2023

Primary completion

October 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 60 Years

Last updated June 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.